SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
12 clinical trials · Sponsor
◉ Watch SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
| Record | Firm | Date |
|---|---|---|
| To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants (NCT07279233) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-12-15 |
| To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants (NCT07259330) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-10-27 |
| Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (NCT07176689) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-09-17 |
| Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat (NCT07171619) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-08-21 |
| A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) (NCT07170644) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-08-08 |
| Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib (NCT06997276) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2025-05-07 |
| SW-682 in Advanced Solid Tumors (NCT06251310) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2024-07-31 |
| Mirdametinib + BGB-3245 in Advanced Solid Tumors (NCT05580770) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2023-02-03 |
| MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (NCT03962543) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2019-09-29 |
| Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (NCT03785964) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 2019-04-17 |
| Individual Patient Compassionate Use of Mirdametinib (NCT05028166) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | |
| Individual Patient Compassionate Use of Nirogacestat (NCT05041036) | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany |
Track SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany automatically
Every clearance here is in the API, with alerts when new ones post.